If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2021-02-02 11:12 (28 d 12:41 ago) – Posting: # 22200
Views: 335

Hi libaiyi,

» (...) So my quesion is if we have any method to widen the CI like RSABE in cross-over study?

I don't think there is any authority generally willing to widen the acceptance range in parallel trials involving humans (they'd perhaps do it if you were studying pMDI's in vitro etc).

Pass or fail!

Complete thread:

 Admin contact
21,359 posts in 4,460 threads, 1,492 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 23:54 CET (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz